603233.SH
大参林
SSE · Healthcare · Biotechnology · CN
CNY 17.36
−1.70%Margins
Gross margin
34.6%
EBITDA margin
8.7%
EBIT margin
7.0%
Net margin
4.7%
FCF margin
14.7%
16.3%
Return on equity
4.8%
Return on assets
18.3%
Return on invested capital
1.03x
Asset turnover
CNY 4.6B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026